Embecta Corp. (EMBC)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.10
+0.49%
Mkt Cap $200.53M
Analyst Ratings
Buy
1
Hold
3
Sell
1
Price Target (7 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+61.6%
Consensus $5.00 vs current $3.10